Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Helyezés a részvények között #39467
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Részvényárfolyam
$0.11725176
Utolsó szinkronizálás: 2025-07-14
Piaci kapitalizáció
$481.50K
Változás (1 nap)
-0.20%
Változás (1 év)
0.00%
Ország
FR
Kereskedés PHAXIAM Therapeutics S.A. (PHXM)

Kategória

PHAXIAM Therapeutics S.A. (PHXM) osztalékhozamának története
PHAXIAM Therapeutics S.A. (tőzsdei szimbólum: PHXM) osztalékhozama (TTM) 2022-12-31 állapot szerint: 0.00%
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
PHAXIAM Therapeutics S.A. (PHXM) osztalékhozamainak története 2016 és 2026 között
Éves záró osztalékhozam (TTM)
Év Osztalékhozam Változtassa meg
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)